800-350-6003

Regeneron Pharmaceuticals Inc.

Robbins LLP Is Investigating Regeneron Pharmaceuticals, Inc. (REGN) Officials on Behalf of Shareholders

Robbins LLP are investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. Regeneron Pharmaceuticals develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide.

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

Send us a message for more information.

Additional Alerts for Shareholders

Yiren

Yiren Digital Ltd. Class Action Lawsuit

October 29, 2026

Robbins LLP is Investigating Allegations that Yiren Digital Ltd. (YRD) Misled Investors By Failing to Disclose Its Significant Exposure to the Financial Distress, Credit Risk, and Legal and Regulatory Problems of Its Controlling Shareholder, CreditEase, and Related Affiliates

Read More »
Facebook-f X-twitter Linkedin

Attorney Advertising.  Past results do not guarantee a similar outcome.

5060 Shoreham Pl., Ste. 300 San Diego, CA 92122

Disclaimer | Site Map | Privacy Policy

© 2026 – Robbins LLP

Free!
Skip to content